Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
02. March 2026
Search
medline.ch
Oncology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 95671
Articles 1 - 20 / 1913408
Identity transformation after breast cancer: A qualitative study informed by attention reorientation.
Eur J Oncol Nurs
Li C, Li J, Rosenzweig MQ, Liu JE.
PMID: 41764798 [PubMed - as supplied by publisher]
The impact of morbidity burden on cancer diagnosis; a retrospective cohort study in England.
Cancer Epidemiol
Wiering B, Mounce LTA, Price SJ, Shotter D, Valderas JM, Merriel SWD, Moore S, Farmer L, Wagner CV, Payne RA, Renzi C, Lyratzopoulos G, Hamilton W, Abel GA.
PMID: 41764785 [PubMed - as supplied by publisher]
Advanced Drug Delivery Strategies for Overcoming Biological Barriers: Tumor Microenvironment and Blood-Brain Barrier.
Drugs R D
Lei Y, Xiao T, Hu X, Lin H.
PMID: 41764714 [PubMed - as supplied by publisher]
A phase II study evaluating pharmacokinetics and dosimetry of (177)Lu-PSMA-617 radioligand therapy in Chinese participants with progressive metastatic castration-resistant prostate cancer.
EJNMMI Res
Shi H, Guo J, Fan W, Li Y, Huang R, Dong Q, Yang Z, Yang Y, Wang X, Gu D, Huo L, Ji Z, Wang F, Xu D, Jiang Z, Li H, Li J, Li R, Qi L, Wang J, Ye D.
PMID: 41764712 [PubMed - as supplied by publisher]
AMDRP: adaptive drug feature fusion and multihead bidirectional cross-attention network for drug-cancer cell response prediction.
Mol Divers
Han S, Huang K, Shi J, Wang J.
PMID: 41764696 [PubMed - as supplied by publisher]
Three novel concomitant NTRK2 fusions in medullary thyroid carcinoma with diagnostic implications.
Discov Oncol
Chu J, Zhao N, Yu Q, Qin L, Zhang D.
PMID: 41764689 [PubMed - as supplied by publisher]
Assessing the assessment: a scoping review of the mode of patient-reported outcome assessment in solid cancer clinical trials.
Qual Life Res
Hubel N, Krepper D, van der Weijst L, Machingura A, Seidl C, Vorbach SM, Veil M, Giesinger JM, Sztankay M, Kern S, Fitzsimmons D, Kuli, Pe M, Holzner B, Lehmann J, EORTC Quality of Life Group.
PMID: 41764668 [PubMed - in process]
Approaches in Skin Cancer Management: Treatment, Early Detection, and Patient-Centric Therapies.
Curr Pharm Des
Tripathy S, Shah K, Sarkar R, Dewangan HK.
PMID: 41764623 [PubMed - as supplied by publisher]
The Diagnostic and Prognostic Potential of Serum Taurine and PUMA in Staging Colorectal Cancer Patients.
Recent Pat Biotechnol
Elashry MA, Samir S, Elrefaiy M, Hammam O, Abu-Taleb H, Ossama Y, Elmeligy HA.
PMID: 41764612 [PubMed - as supplied by publisher]
TEAD4 Identified as a Potential Biomarker for Gastric Cancer Via Genes Associated with Liquid-Liquid Phase Separation.
Curr Protein Pept Sci
Liu J, Zhang J, Gong A.
PMID: 41764605 [PubMed - as supplied by publisher]
Postoperative intravenous lidocaine infusion for pain management in pelvic bone tumor surgery patients: a randomized, double-blind, controlled trial.
J Anesth Analg Crit Care
Huo F, Zhang R, Wu Y, Tian X, Feng Y.
PMID: 41764583 [PubMed - as supplied by publisher]
Baseline PD-L1 expression on circulating immune cells as a predictor of survival and immune-related adverse events in extensive-stage small-cell lung cancer patients treated with durvalumab and carboplatin-etoposide (NCT04712903 Trial).
J Transl Med
Piedra A, Guinart-Cuadra A, Martínez-Recio S, Mulet M, Zamora C, Osuna-Gómez R, Cantó E, Ortiz MA, Alejandre J, Barba A, Sanz-Beltrán J, Serra-López J, Isla D, Arriola E, Paz-Ares L, Diz-Taín MP, Moreno AL, Callejo Á, Vidal S, Majem M.
PMID: 41764558 [PubMed - as supplied by publisher]
Fast and reliable machine learning-based detection of postoperative intracranial infections in brain tumor patients: a diagnostic study using routine CSF parameters.
Cancer Cell Int
Ding S, Dong X, Zhou W, Xing J, Ye X, Song X.
PMID: 41764544 [PubMed - as supplied by publisher]
Prevalence of cervical cancer and its associated factors among women living with HIV attending public referral hospitals in Amhara Region, Ethiopia, 2025, a cross-sectional study.
BMC Infect Dis
Mengistie MB, Ayalew WL, Mengistie SK, Gebeyehu AS, Tizie SB, Mekonen AA, Ayalew ML.
PMID: 41764484 [PubMed - as supplied by publisher]
Racial, ethnic, gender and age representation of clinical trials supporting FDA approval of cancer therapies.
Int J Equity Health
Zhao M, Jiang Y, Shao T, Tang W.
PMID: 41764473 [PubMed - as supplied by publisher]
Regulatory roles of microRNAs in signaling pathways and their biomarker potential in prostate cancer.
Cancer Cell Int
Kalarestaghi H, Amani N, Shoorei H.
PMID: 41764450 [PubMed - as supplied by publisher]
Ultrasound-Responsive Engineered Bacteria for Targeted Cancer Therapy: Strategies, Mechanisms, and Applications.
Adv Sci (Weinh)
Wang X, Xu W, Lu Y, Yu H, Zha Z, Zhang X.
PMID: 41764403 [PubMed - as supplied by publisher]
The impact of different exercise modes on prostate cancer: a Bayesian network meta-analysis.
Sci Rep
Liu J, Li Q, Han Y.
PMID: 41764301 [PubMed - as supplied by publisher]
Exploring the optimal follow-up time for resectable colorectal cancer patients: a multicenter, five-year longitudinal cohort study.
Sci Rep
Kang B, Qiao Y, Wang Y, Li Y, Hu B, Zhang Z, Wang Q, Zhu J, Li J.
PMID: 41764294 [PubMed - as supplied by publisher]
Skin Cancer in Solid Organ Transplant Recipients: A Review.
Am J Clin Dermatol
van Ammers M, Chong AH.
PMID: 41764150 [PubMed - as supplied by publisher]
Articles 1 - 20 / 1913408
Page 1 of 95671
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy